1. Yanagiya R, *Nakagawa S, Onizuka M, Kotani A. Aberrant expression of Human Endogenous Retrovirus K9-derived elements is associated with better clinical outcome of acute myelocytic leukemia. Retroviology in press
2. Kamakura T, Kameda K, Manabe M, Torii K, Sugiura Y, Ito S, Nakayama S, Shimizu T, Nagashima E, Kamiya K, Oka M, Tanaka M, Otsuka M, Ohtsuka M, *Kotani A. PTBP1 protects Y RNA from cleavage leading to its apoptosis-specific degradation. Cell Death Discov. 2024 Jul 12;10(1):322.
3. Yanagiya R, Miyatake Y, Watanabe N,Shimizu T,Kanamori A,Ueno M,Okabe S,Carreras J, Nakayama S,Hasegawa A,Kameda K,Nakagawa S,Yamauchi T,Maeda T,Ishii K,Matsuura T,Handa H, Hirao A,Ishizawa K,Onizuka M,Mashima T,Nakamura N, Ando K, *Kotani A. Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia.Leukemia 2024 38(8):1731-1741.
4. Kudo K,Yanagiya R,*Hasegawa M,Carreras J,Miki Y,Nakayama S,Nagashima E,Miyatake Y,Torii K, Ando K,Nakamura N,Miyajima A,Murakami M,*Kotani A. Unique lipid composition maintained by extracellular blockade leads to prooncogenicity. Cell Death and Discov. 2024,221
5. Miura H, Nakamura A, Kurosaki A, Kotani A, Motojima M, Tanaka K, Kakuta S, Ogiwara S, Ohmi Y, Komaba H, Schilit SLP, Morton CC, Gurumurthy CB, Ohtsuka M. Targeted insertion of conditional expression cassettes into the mouse genome using the modified i-PITT. BMC Genomics. 2024 Jun 5;25(1):568.
6. Sawayama, R., Minoda, M., Kojima, H., Okabe, T., Isayama, Y., Kato, K., Nishimasu, H., Urano, Y.* & Komatsu, T.* “Application of Intramolecular O-to-N Phosphoryl Transfer Reaction to Design Fluorogenic Probes to Detect Activities of Enzymes That Metabolize Short Peptides and Acylamino Acids” ACS Sensors (2025), 10, 664-670
7. Minoda, M., Hatakeyama, J., Nagano, N., Mizuno, T., Iwasaka, T., Shiga, S., Takahashi, K., Hiraide, H., Sakamoto, S., Kagami, Y., Kashiro, A., Honda, K., Sugiura, Y., Mishima, K., Kaneko Mishima, M., Kusuhara, H., Urano, Y.*, & Komatsu, T*. “Single-Molecule Oxidoreductase Activity Analysis for Activity-Based Diagnosis Based on Proteoform Alterations” J. Am. Chem. Soc. (2025), 147, 4743-4751.